Corpus Intelligence ZUCKERBERG SAN FRANCISCO GENERAL — History 2026-04-26 03:45 UTC
ZUCKERBERG SAN FRANCISCO GENERAL — History
CCN 050228 | 3-year financial timeline | COVID resilience: 73/100
🛡️ Public data only — no PHI permitted on this instance.
$890M
Latest Revenue (FY2022)
+5.3%
Revenue CAGR (3yr)
-41.7%

Financial Timeline

MetricFY2020FY2021FY2022YoY (Latest)CAGR
Net Patient Revenue$803M$874M$890M+1.8%+5.3%
Operating Expenses$1.2B$1.0B$1.3B+20.4%+0.5%
Operating Margin-55.5%-19.8%-41.7%-110.7%+0.0%
Net Income$-445M$-173M$-371M-114.4%+0.0%
Licensed Beds284284284+0.0%+0.0%
Total Patient Days80,18681,54289,196+9.4%+5.5%
Medicare Day %24%23%21%-9.6%-7.0%
Medicaid Day %21%19%16%-19.0%-14.2%

COVID Impact & Recovery

Resilience Score: 73/100 — Moderate — some COVID impact but recovering

Revenue recovery from FY2020 to FY2022: +10.8% ($803M → $890M)

FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.

Trend Summary

Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing

vs State Average ()

Revenue Growth
+5.3%
This Hospital
+7.6%
State Avg
Latest Margin
-41.7%
This Hospital
-4.6%
State Avg

Projections (FY2023-2025)

Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.

YearRevenue (proj)Margin (proj)
FY2023 (proj)$933M-34.9%
FY2024 (proj)$976M-28.0%
FY2025 (proj)$1.0B-21.1%